The Role of Multimodality Imaging in Left Atrial Appendage Closure
Hungarian Institute of Cardiology
44 participants
Nov 8, 2021
INTERVENTIONAL
Conditions
Summary
The aim of the present prospective, randomized single-centre study is to examine the success rate, safety, overall preoperative and operative burden and long-time outcome of percutaneous left atrial appendage closure procedures after unimodal and multimodal preprocedural imaging. According to the investigators' primary hypothesis, simple, unimodal preprocedural imaging does not increase procedural burden of LAAC (total radiation dose, procedure time, fluoroscopy time, contrast amount). The investigators assume, that the success rate and safety of LAAC procedures is not reduced using unimodal preoperative imaging. Regarding to postoperative imaging, the investigators aim to compare the sensitivity of different imaging techniques in detecting postoperative complications. We assume, that multimodal imaging technique increases the accuracy and sensitivity of the detection of postoperative complications (PDL, device thrombi).
Eligibility
Inclusion Criteria4
- Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025
- Age above 18 years
- Informed consent
- Legal capacity
Exclusion Criteria14
- Age under 18 years
- Pregnancy
- Incapacitation
- Absence of consent
- Esophageal stenosis or diverticulum
- Active esophageal bleeding
- CT-contrast agent allergy
- Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2)
- Appendage thrombus (mobile/with significant embolic risk)
- Life expectancy shorter than 12 months
- Active infection
- Significant mitral valve stenosis
- Mechanical heart valve
- Open heart surgery is indicated
Interventions
Preoperative 2D/3D TOE and MDCT, operative 2D/3D TOE and fluoroscopy/angiography, postoperative 2D/3D TOE and MDCT
Preoperative MDCT, operative 2D/3D TOE and fluoroscopy/angiography, postoperative 2D/3D TOE and MDCT
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04800913